Novo Nordisk's Shares Go on a Rollercoaster Ride After Earnings

Novo Nordisk A/S TodayNVONovo Nordisk A/S $128.17 +8.94 (+7.50%) 52-Week Range$ 86.96▼ $148.15Dividend Yield1.03%P/E Ratio44.20Price Target$ 145.17Add to WatchlistNovo Nordisk NYSE: NVO is the world’s second-largest pharmaceutical company, with a market capitalization of $538 billion. The Danish firm’s shares have performed well so far in 2024, returning 23%, outperforming its sector. The iShares Global Healthcare ETF NYSEARCA: IXJ has returned 11%.The firm's standout performance largely stems from its successf ...